Eleven Biotherapeutics, Inc.

New Filing
CIK: 0001485003·Biotechnology·DELAWARE·Filed: Feb 24, 2010
Total Offering

$35,000,000

Amount Sold

$4,500,000

Investors

2

First Sale

Feb 9, 2010

Offering Details

Type
Equity, Security to be Acquired
Exemptions
Rule 506
Entity Type
Corporation
Year Incorporated
2008
Non-Accredited Investors
No

Related Persons

NameRole
Mark Levin
Related Person
David M Berry
Related Person
Noubar B. Afeyan
Related Person
Cary Pfeffer
Related Person
Kim C. Drapkin
Related Person

Company

Eleven Biotherapeutics, Inc.

790 MEMORIAL DRIVE

CAMBRIDGE, MA, 02139

617-494-0768

SEC Filing

0001485003-10-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free